isoxazoles has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jackson, M; North, EJ; Sethiya, JP; Sowards, MA | 1 |
1 review(s) available for isoxazoles and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biological Transport; Drug Discovery; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Humans; Iodophors; Isoxazoles; Membrane Transport Proteins; Mycobacterium Infections, Nontuberculous; Mycolic Acids; Nontuberculous Mycobacteria; Polysaccharides; Spiro Compounds | 2020 |